Egyszerű nézet

dc.contributor.author Nemoda Zsófia
dc.contributor.author Lyons-Ruth K
dc.contributor.author Székely Anna
dc.contributor.author Bertha E
dc.contributor.author Faludi Gábor
dc.contributor.author Sasvári-Székely Mária
dc.date.accessioned 2014-12-12T08:30:17Z
dc.date.available 2014-12-12T08:30:17Z
dc.date.issued 2010
dc.identifier 76949083115
dc.identifier.citation pagination=4; journalVolume=6; journalTitle=BEHAVIORAL AND BRAIN FUNCTIONS;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/764
dc.identifier.uri doi:10.1186/1744-9081-6-4
dc.description.abstract Background: In the development of borderline personality disorder (BPD) both genetic and environmental factors have important roles. The characteristic affective disturbance and impulsive aggression are linked to imbalances in the central serotonin system, and most of the genetic association studies focused on serotonergic candidate genes. However, the efficacy of dopamine D2 receptor (DRD2) blocking antipsychotic drugs in BPD treatment also suggests involvement of the dopamine system in the neurobiology of BPD.Methods: In the present study we tested the dopamine dysfunction hypothesis of impulsive self- and other-damaging behaviors: borderline and antisocial traits were assessed by Structured Clinical Interview for Diagnosis (SCID) for DSM-IV in a community-based US sample of 99 young adults from low-to-moderate income families. For the BPD trait analyses a second, independent group was used consisting of 136 Hungarian patients with bipolar or major depressive disorder filling out self-report SCID-II Screen questionnaire. In the genetic association analyses the previously indicated polymorphisms of the catechol-O-methyl-transferase (COMT Val158Met) and dopamine transporter (DAT1 40 bp VNTR) were studied. In addition, candidate polymorphisms of the DRD2 and DRD4 dopamine receptor genes were selected from the impulsive behavior literature.Results: The DRD2 TaqI B1-allele and A1-allele were associated with borderline traits in the young adult sample (p = 0.001, and p = 0.005, respectively). Also, the DRD4 -616 CC genotype appeared as a risk factor (p = 0.02). With severity of abuse accounted for in the model, genetic effects of the DRD2 and DRD4 polymorphisms were still significant (DRD2 TaqIB: p = 0.001, DRD2 TaqIA: p = 0.008, DRD4 -616 C/G: p = 0.002). Only the DRD4 promoter finding was replicated in the independent sample of psychiatric inpatients (p = 0.007). No association was found with the COMT and DAT1 polymorphisms.Conclusions: Our results of the two independent samples suggest a possible involvement of the DRD4 -616 C/G promoter variant in the development of BPD traits. In addition, an association of the DRD2 genetic polymorphisms with impulsive self-damaging behaviors was also demonstrated. © 2010 Nemoda et al; licensee BioMed Central Ltd.
dc.relation.ispartof urn:issn:1744-9081
dc.title Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients
dc.type Journal Article
dc.date.updated 2014-12-11T13:51:25Z
dc.language.rfc3066 en
dc.identifier.mtmt 1668704
dc.identifier.wos 000275179400001
dc.identifier.pubmed 20205808
dc.contributor.department SE/ÁOK/K/Kútvölgyi Klinikai Tömb egyéb osztályok
dc.contributor.department SE/ÁOK/I/Orvosi Vegytani, Molekuláris Biológiai és Patobiokémiai Intézet
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet